Loading
Kevin Outterson

Kevin Outterson

Executive Director, CARB-X
United States
Kevin Outterson, J.D., LL.M., is Professor of Law and Austin B. Fletcher Professor of Law at Boston University, where he co-directs the Health Law Program and leads the Social Innovation on Drug Resistance program. He is also the founding Executive Director and Principal Investigator of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership funded by the U.S., U.K., and German governments, Wellcome and the Bill & Melinda Gates Foundation. Its mission is to accelerate a diverse portfolio of innovative antibacterial products toward clinical development and regulatory approval. The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibacterial therapeutics, diagnostics, and prevention. CARB-X is the only global partnership that includes prevention, diagnosis, and treatment of life-threatening bacterial infections. CARB-X has been awarded over $800 million in grants with Professor Outterson as Principal Investigator.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS